Literature DB >> 21713427

Correlation between maternal hepatitis B surface antigen carrier status with social, medical and family factors in an endemic area: have we overlooked something?

O K Chan1, T T Lao, S S H Suen, T K Lau, T Y Leung.   

Abstract

PURPOSE: Hepatitis B virus (HBV) infection is endemic in many countries, but the risk factors for HBV carriage in the obstetric population are unclear.
METHODS: A survey on 1,580 women attending the antenatal clinic in an endemic region was conducted in order to examine the prevalence of and factors associated with maternal HBV carriage, including socio-demographic, medical, and previous obstetrical and family history, by means of a questionnaire.
RESULTS: The prevalence of maternal HBV carriage was 9.1%, and 4.8% of women with a history of hepatitis B vaccination were found to be HBV carriers. Factors associated with maternal HBV carriage were residency status (adjusted odds ratio [aOR] 3.65 for immigrants; aOR 7.62 for non-residents), positive family history (aOR 3.72 for infected mother; aOR 5.36 for other family members), no previous vaccination (aOR 4.39) and having previous HBsAg testing (aOR 2.26).
CONCLUSIONS: The findings suggest that there was probably an overlooked role of horizontal transmission within the family setting in addition to perinatal transmission in determining the likelihood of HBV infection in our obstetric population. Reconfirmation of hepatitis B status might be necessary among individuals with a history of vaccination to ensure the effectiveness of their immunoprotection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21713427     DOI: 10.1007/s15010-011-0151-3

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  42 in total

1.  Hepatitis B infection in Eastern Indian families: need for screening of adult siblings and mothers of adult index cases.

Authors:  R Chakravarty; A Chowdhury; S Chaudhuri; A Santra; M Neogi; K Rajendran; C K Panda; M Chakravarty
Journal:  Public Health       Date:  2005-07       Impact factor: 2.427

2.  Five-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasma-derived vaccine in children: immunogenicity and anamnestic responses.

Authors:  C L Lai; B C Wong; E K Yeoh; W L Lim; W K Chang; H J Lin
Journal:  Hepatology       Date:  1993-10       Impact factor: 17.425

Review 3.  Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China.

Authors:  G B Yao
Journal:  Gut       Date:  1996       Impact factor: 23.059

4.  Heterogeneity of hepatitis B transmission in Tunisia: risk factors for infection and chronic carriage before the introduction of a universal vaccine program.

Authors:  Nissaf Ben-Alaya-Bouafif; Olfa Bahri; Sadok Chlif; Jihène Bettaieb; Amine Toumi; Hamida Nabil Bel Haj; Amor Zâatour; Adel Gharbi; Koussay Dellagi; Hinda Triki; Afif Ben Salah
Journal:  Vaccine       Date:  2010-03-10       Impact factor: 3.641

5.  Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen.

Authors:  P I Lee; C Y Lee; L M Huang; M H Chang
Journal:  J Pediatr       Date:  1995-05       Impact factor: 4.406

6.  Hepatitis B virus infection in Chinese families in Hong Kong.

Authors:  A S Lok; C L Lai; P C Wu; V C Wong; E K Yeoh; H J Lin
Journal:  Am J Epidemiol       Date:  1987-09       Impact factor: 4.897

7.  Implications of the relationship between maternal age and parity with hepatitis B carrier status in a high endemicity area.

Authors:  S S H Suen; T T Lao; D S Sahota; T K Lau; T Y Leung
Journal:  J Viral Hepat       Date:  2009-09-25       Impact factor: 3.728

8.  Transmission of hepatitis B virus to gibbons by exposure to human saliva containing hepatitis B surface antigen.

Authors:  W H Bancroft; R Snitbhan; R M Scott; M Tingpalapong; W T Watson; P Tanticharoenyos; J J Karwacki; S Srimarut
Journal:  J Infect Dis       Date:  1977-01       Impact factor: 5.226

9.  Risk factors for hepatitis B infection in rural Vietnam.

Authors:  Thai Hong Duong; Phuong Hong Nguyen; Keith Henley; Marion Peters
Journal:  Asian Pac J Cancer Prev       Date:  2009 Jan-Mar

10.  Epidemiology and Prevention of Hepatitis B Virus Infection.

Authors:  Jinlin Hou; Zhihua Liu; Fan Gu
Journal:  Int J Med Sci       Date:  2005-01-05       Impact factor: 3.738

View more
  6 in total

1.  Conventional and genetic risk factors for chronic Hepatitis B virus infection in a community-based study of 0.5 million Chinese adults.

Authors:  Elizabeth Hamilton; Ling Yang; Alexander J Mentzer; Yu Guo; Yiping Chen; Jun Lv; Robert Fletcher; Neil Wright; Kuang Lin; Robin Walters; Christiana Kartsonaki; Yingcai Yang; Sushila Burgess; Sam Sansome; Liming Li; Iona Y Millwood; Zhengming Chen
Journal:  Sci Rep       Date:  2022-07-15       Impact factor: 4.996

2.  Immune persistence after hepatitis B vaccination in infancy - Fact or fancy?

Authors:  Terence T Lao
Journal:  Hum Vaccin Immunother       Date:  2016-01-25       Impact factor: 3.452

3.  Deficient knowledge on hepatitis B infection in pregnant women and prevalence of hepatitis B surface antigen carriage in an endemic area: a review.

Authors:  Oi Ka Chan; Terence T Lao; Stephen S H Suen; Tak Yeung Leung
Journal:  Hepat Res Treat       Date:  2012-09-28

4.  Do prior contraceptive methods impact maternal carriage in patients with hepatitis B?

Authors:  Terence T Lao; Oi Ka Chan; Stephen Sik Hung Suen; Tak Yeung Leung
Journal:  Hepat Mon       Date:  2011-10       Impact factor: 0.660

5.  Age-specific prevalence of hepatitis B virus infection in young pregnant women, Hong Kong Special Administrative Region of China.

Authors:  Terence T Lao; Daljit S Sahota; Lai-Wa Law; Yvonne K Y Cheng; Tak-Yeung Leung
Journal:  Bull World Health Organ       Date:  2014-09-03       Impact factor: 9.408

6.  Impact of neonatal hepatitis B vaccination programme on age-specific prevalence of hepatitis B infection in teenage mothers in Hong Kong.

Authors:  T T Lao; D S Sahota; S S H Suen; P K S Chan; T Y Leung
Journal:  Epidemiol Infect       Date:  2012-12-05       Impact factor: 4.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.